News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Even weak evidence 3 drugs better than 2 – Vinay Prasad
Photo from Vinay Prasad/Twitter
Jul 6, 2023, 05:11

Even weak evidence 3 drugs better than 2 – Vinay Prasad

New paper this week walks through the RCT landscape in myeloma and shows poor post-protocol therapy.

As a result, there is very little evidence what the optimum sequence should be; Even weak evidence 3 drugs better than 2

For details: Click here

Source: Vinay Prasad/Twitter

cancer Cancer Support Drugs frontiersin Myeloma OncoDaily Oncology Pharma Research therapy Vinay Prasad
Special Coverage
Blog
Mar 30, 2025, 03:54
Karen Knudsen: Thomas Lynch on how to address headwinds to cancer science and cancer care delivery
Blog
Mar 30, 2025, 03:45
Miriam Mutebi: We are looking for ways to expand surgical capacity in Africa
Blog
Mar 30, 2025, 03:34
Optimizing Interdisciaplinary Psychosocial Support and more - National Comprehensive Cancer Network
Blog
Mar 30, 2025, 03:26
Celebrating 1,000 Followers on LinkedIn - The Babak Lab
Blog
Mar 30, 2025, 03:18
Gregg Margolis: A very big week in health policy
Blog
Mar 30, 2025, 00:07
Abbigail and Team LUNGevity continue their final weeks of training for the Big Sur Marathon: LUNGevity Foundation
Career
Mar 29, 2025, 23:56
Arun Srivastava has been named a 2024 fellow of the AAAS: UF Health Cancer Center
Insight
Mar 29, 2025, 23:37
Sitna Ali Mwanzi: Molecular Profile of NSCLC in a predominantly Black African Population in Kenya
Blog
Mar 29, 2025, 23:14
Join us live for the Open Plenary Session: Common Sense Oncology
Insight
Mar 29, 2025, 23:04
Naveen Pemmaraju: Polycythemia vera: past, present and future
Insight
Mar 29, 2025, 21:34
Elvina Almuradova: Pembrolizumab plus CRT as the New Standard in Locally Advanced Cervical Cancer
Blog
Mar 29, 2025, 21:16
Shivani Modi: Honored to present 3 posters at ASCO and 5 published abstracts